DK151627C - Analogifremgangsmaade til fremstilling af terapeutisk virksomme 4-(fenylalkenyl)-imidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf. - Google Patents

Analogifremgangsmaade til fremstilling af terapeutisk virksomme 4-(fenylalkenyl)-imidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf.

Info

Publication number
DK151627C
DK151627C DK057281A DK57281A DK151627C DK 151627 C DK151627 C DK 151627C DK 057281 A DK057281 A DK 057281A DK 57281 A DK57281 A DK 57281A DK 151627 C DK151627 C DK 151627C
Authority
DK
Denmark
Prior art keywords
sub
acid addition
addition salts
compounds
acceptable acid
Prior art date
Application number
DK057281A
Other languages
Danish (da)
English (en)
Other versions
DK151627B (da
DK57281A (da
Inventor
Arto Johannes Karjalainen
Kauko Oiva Antero Kurkela
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of DK57281A publication Critical patent/DK57281A/da
Publication of DK151627B publication Critical patent/DK151627B/da
Application granted granted Critical
Publication of DK151627C publication Critical patent/DK151627C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
DK057281A 1980-02-13 1981-02-11 Analogifremgangsmaade til fremstilling af terapeutisk virksomme 4-(fenylalkenyl)-imidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf. DK151627C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8004748 1980-02-13
GB8004748A GB2069481B (en) 1980-02-13 1980-02-13 Substituted imidazole derivatives

Publications (3)

Publication Number Publication Date
DK57281A DK57281A (da) 1981-08-14
DK151627B DK151627B (da) 1987-12-21
DK151627C true DK151627C (da) 1988-06-20

Family

ID=10511309

Family Applications (2)

Application Number Title Priority Date Filing Date
DK057281A DK151627C (da) 1980-02-13 1981-02-11 Analogifremgangsmaade til fremstilling af terapeutisk virksomme 4-(fenylalkenyl)-imidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf.
DK057181A DK157861C (da) 1980-02-13 1981-02-11 Analogifremgangsmaade til fremstilling af 4-substituerede fenylalkylimidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK057181A DK157861C (da) 1980-02-13 1981-02-11 Analogifremgangsmaade til fremstilling af 4-substituerede fenylalkylimidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf

Country Status (17)

Country Link
US (3) US4333947A (fr)
EP (2) EP0034473B1 (fr)
JP (2) JPS56128768A (fr)
AT (2) ATE2322T1 (fr)
AU (2) AU528275B2 (fr)
CA (2) CA1167454A (fr)
DD (1) DD156260A1 (fr)
DE (2) DE3160905D1 (fr)
DK (2) DK151627C (fr)
FI (2) FI73415C (fr)
GB (1) GB2069481B (fr)
IE (2) IE50771B1 (fr)
IL (2) IL62111A (fr)
NO (2) NO154089C (fr)
NZ (2) NZ196250A (fr)
SU (1) SU1074404A3 (fr)
ZA (2) ZA81978B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI843245A (fi) * 1983-08-17 1985-02-18 Syntex Inc Alfa-allen-alfa-aminosyror.
JPH062746B2 (ja) * 1984-07-23 1994-01-12 三井石油化学工業株式会社 イミダゾ−ル類の製造方法
LU85747A1 (fr) * 1985-01-28 1986-08-04 Continental Pharma Derives d'imidazole leur preparation et utilisation ainsi que les compositions pharmaceutiques contenant des derives
GB8523255D0 (en) * 1985-09-20 1985-10-23 Shell Int Research Imidazoles
DE3539629A1 (de) * 1985-11-08 1987-05-14 Basf Ag Dialkoxyketone und ein verfahren zu ihrer herstellung
US4882343A (en) * 1987-08-28 1989-11-21 G. D. Searle & Co. Biarylalkylimidazole derivatives as anti-depressants
GB2210875B (en) * 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
GB8726110D0 (en) * 1987-11-06 1987-12-09 Shell Int Research Imidazole ketone derivatives
US5354867A (en) * 1988-12-06 1994-10-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5304569A (en) * 1989-11-13 1994-04-19 Orion-Yhtyma Oy Compositions and their use in lowering intraocular pressure
DE4003243A1 (de) * 1990-02-03 1991-08-08 Basf Ag Verwendung von trialkanolaminpolyethern als demulgatoren von oel-in-wasser-emulsionen
DE4006255A1 (de) * 1990-02-28 1991-08-29 Basf Ag Als emulgatoren von oel-in-wasser-emulsionen geeignete kondensationsprodukte
GB2256135B (en) 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
DE4136661A1 (de) * 1991-11-07 1993-05-13 Basf Ag Erdoelemulsionsspalter
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
FR2732017B1 (fr) * 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
CA2222099A1 (fr) * 1995-05-30 1996-12-05 Gliatech, Inc. Derives imidazole 1h-4(5)-substitues
JPH099441A (ja) * 1995-06-21 1997-01-10 Yoshinari Denki Kogyosho:Kk ケーブルベンダー
US6486156B1 (en) * 1998-12-23 2002-11-26 Astrazeneca Ab Chemical compounds
MXPA05009290A (es) 2003-03-07 2006-05-31 Astellas Pharma Inc Derivados heterociclicos que contienen nitrogeno que tienen estirilo 2,6-disustituido.
EP1918282A1 (fr) 2006-11-06 2008-05-07 "Joint Stock Company Grindeks" Procédé pour la préparation de medetomidine et ses sels
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
CN118715219A (zh) * 2022-01-20 2024-09-27 瓦勒莱塞逊瑞彻弛Hscm有限合伙公司 消退素类似物化合物及其方法和用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946804A (en) * 1958-12-29 1960-07-26 Abbott Lab (5-methyl-4-imidazolyl)-diphenyl carbinol salts and lower alkyl quaternaries
US3050520A (en) * 1960-03-31 1962-08-21 Air Prod & Chem Process of preparing 2-olefinic imidazoles
US3188315A (en) * 1960-05-18 1965-06-08 Schering Corp Novel compounds for lowering blood cholesterol levels
US3202660A (en) * 1961-10-09 1965-08-24 Boehringer Sohn Ingelheim Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
US3448108A (en) * 1965-04-16 1969-06-03 Schering Corp Substituted phenethyl heterocycles and their derivatives
US3502661A (en) * 1967-02-14 1970-03-24 Pfizer & Co C Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl) pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
US3812111A (en) * 1972-12-04 1974-05-21 Commercial Solvents Corp Imidazoline tranquilizing agents
IE40911B1 (en) * 1974-04-11 1979-09-12 Schering Ag Imidazole derivatives and process for their manufacture
US3991201A (en) * 1974-06-27 1976-11-09 Janssen Pharmaceutica N.V. 1-(β-Aryl-β-R-ethyl)imidazoles as antimicrobial agents
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
US4006137A (en) * 1975-08-21 1977-02-01 E. R. Squibb & Sons, Inc. 2-Ethenyl imidazolium derivatives
US4115578A (en) * 1975-12-18 1978-09-19 Rohm And Haas Company 1-Substituted aralkyl imidazoles
IL55800A (en) * 1977-10-26 1982-05-31 Wellcome Found Imidazoline derivatives,their preparation and their use as arthropodicides
GB2025934B (en) * 1978-06-22 1982-08-04 Grissmann Chem Ltd (1 - alkyl - 5 - nitro - 2 - imidozolyl)-vinylglyoxal-diacetals their preparation and their use
IT1097314B (it) * 1978-07-26 1985-08-31 Recordati Chem Pharm Derivati dell'imidazolo ad attivita' anticonvulsivante
DE2851116A1 (de) * 1978-11-25 1980-06-12 Bayer Ag Hydroxyethyl-azole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4260626A (en) * 1979-03-26 1981-04-07 Richardson-Merrell Inc. Tetrahydro and imidazoline antisecretory compounds
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
FI73416B (fi) 1987-06-30
DE3160036D1 (en) 1983-03-03
SU1074404A3 (ru) 1984-02-15
DK157861C (da) 1990-07-30
CA1167454A (fr) 1984-05-15
NO154089C (no) 1986-07-16
DE3160905D1 (en) 1983-10-27
US4333947A (en) 1982-06-08
AU528275B2 (en) 1983-04-21
NO810478L (no) 1981-08-14
DK157861B (da) 1990-02-26
NZ196251A (en) 1983-05-31
NO153455C (no) 1986-05-07
CA1160238A (fr) 1984-01-10
JPS56128768A (en) 1981-10-08
ZA81978B (en) 1982-03-31
GB2069481A (en) 1981-08-26
AU6716381A (en) 1981-08-20
FI810250L (fi) 1981-08-14
GB2069481B (en) 1983-07-27
DK151627B (da) 1987-12-21
FI73415C (fi) 1987-10-09
US4684659A (en) 1987-08-04
EP0034473A3 (en) 1981-11-18
IL62110A (en) 1986-01-31
JPH0215538B2 (fr) 1990-04-12
IE810275L (en) 1981-08-13
FI810389L (fi) 1981-08-14
US4568686A (en) 1986-02-04
ATE4709T1 (de) 1983-10-15
EP0034473B1 (fr) 1983-09-21
AU6716481A (en) 1981-08-20
JPH0249308B2 (fr) 1990-10-29
NO154089B (no) 1986-04-07
EP0034474B1 (fr) 1983-01-26
ZA81977B (en) 1982-03-31
IE50771B1 (en) 1986-07-09
IE810274L (en) 1981-08-13
EP0034474A1 (fr) 1981-08-26
IL62111A (en) 1985-03-31
JPS56128767A (en) 1981-10-08
DD156260A1 (de) 1982-08-11
DK57281A (da) 1981-08-14
ATE2322T1 (de) 1983-02-15
NO153455B (no) 1985-12-16
AU537028B2 (en) 1984-05-31
FI73416C (fi) 1987-10-09
IE50772B1 (en) 1986-07-09
NZ196250A (en) 1983-06-17
DK57181A (da) 1981-08-14
FI73415B (fi) 1987-06-30
EP0034473A2 (fr) 1981-08-26
NO810479L (no) 1981-08-14

Similar Documents

Publication Publication Date Title
DK151627C (da) Analogifremgangsmaade til fremstilling af terapeutisk virksomme 4-(fenylalkenyl)-imidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf.
ATE19878T1 (de) Benzimidazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK158351C (da) Analogifremgangsmaade til fremstilling af substituerede 4-fenylalkylimidazolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK157926C (da) Analogifremgangsmaade til fremstilling af 4-(substitueret aminometyl)-imidazoler eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
ATE25968T1 (de) 1,1-diphenylpropanol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
PBP Patent lapsed